AAN Summer Conference
Supported by a team of world-renowned leaders in the field of autoimmune neurology, Mayo Clinic Laboratories’ testing for immune-mediated neurological disorders is unparalleled. Driven by ongoing discoveries about the role of autoantibody biomarkers in autoimmune neurologic disease, our lab continually validates novel autoantibody profiles that inform clinical decision-making. With evaluations that span the spectrum of autoimmune neurological disorders, our testing enables insights on diagnosis, prognosis, disease management, and treatment efficacy.
Videos, webinars, podcasts, and Hot Topics
The Power of Discovery
Autoimmune encephalopathy evaluation: Why be comprehensive?
Neuroimmunology: Updates and antibody test utilization
Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score
Pediatric Autoimmune CNS Disorders Evaluation
Advancements in Autoimmune Neurology: Dr. Andrew McKeon
Communique, Case Study, and Patient Spotlight
Nailing the suspect: The prevalence of autoimmune encephalitis compared with infectious encephalitis
University of Louisville: Building an evidence-based algorithm to guide autoimmune neurology patient care
Back from the brink: Sheila Lewis
Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations Study
Test Request Form